You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BCNU

Showing 26 - 50 of 189
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Autologous Stem Cell Transplantation, Conditioning Trial in Xi'an (modified BEAM, BEAM)

Not yet recruiting
  • Autologous Stem Cell Transplantation
  • Conditioning
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Apr 14, 2023

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell Trial in China (Chidamide, Cladribine, Gemcitabine)

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, T-Cell
  • Deyang, Deyang, China
  • +10 more
Jul 21, 2022

Mantle Cell Lymphoma, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Houston (procedure, drug, biological)

Completed
  • Mantle Cell Lymphoma
  • +6 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 18, 2022

Peripheral T-Cell Lymphoma Trial in Saint Louis (Gemcitabine, Navelbine, Doxorubicin Hydrochloride Liposome Injection)

Terminated
Has Results
  • Peripheral T-Cell Lymphoma
  • Saint Louis, Missouri
    Washington University
Apr 14, 2020

Triple-Negative Invasive Breast Carcinoma, Residual Tumor Trial in Mexico City (Carmustine, Cyclophosphamide, Carboplatin)

Unknown status
  • Triple-Negative Invasive Breast Carcinoma
  • Residual Tumor
  • Mexico City, Distrito Federal, Mexico
    Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubi
Jan 10, 2020

Multiple Myeloma Trial in Seattle (Allopurinol, Carmustine, Etoposide)

Recruiting
  • Multiple Myeloma
  • Seattle, Washington
    Swedish Cancer Institute
Jun 21, 2022

ASCT Versus Chemotherapy as First-Line Consolidation Therapy

Completed
  • T-cell Lymphoma Adults
  • consolidation with ASCT
  • (no location specified)
Nov 25, 2023

Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (carmustine, cisplatin, cyclophosphamide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019

Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (carmustine, cisplatin, cyclophosphamide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019

Lymphoma Trial in Duarte (biological, drug, procedure)

Completed
  • Lymphoma
  • lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Nov 13, 2019

Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma Trial in Durham, Portland (procedure, drug, other)

Completed
  • Plasma Cell Leukemia
  • Recurrent Plasma Cell Myeloma
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Durham, North Carolina
  • +1 more
Nov 19, 2020

Lymphoma Trial in Baltimore (biological, drug, procedure)

Completed
  • Lymphoma
  • filgrastim
  • +12 more
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 31, 2019

Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)

Recruiting
  • Lymphoma
  • +4 more
  • Pharmacokinetics
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 12, 2022

Burkitt Lymphoma, CD20-Positive Neoplastic Cells Present, DLBCL Trial in Seattle (biological, procedure, drug, radiation, other)

Terminated
Has Results
  • Burkitt Lymphoma
  • +6 more
  • Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 30, 2020

Leukemia, Lymphoma Trial in Baltimore (carmustine, cisplatin, cyclophosphamide)

Completed
  • Leukemia
  • Lymphoma
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019

Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Stem cell infusion
  • +5 more
  • Saint Louis, Missouri
    Washington University
Jan 17, 2023

Lymphoma, Autologous Hematopoietic Stem Cell Transplantation Trial in Xi'an (Improved BEAM regimen)

Not yet recruiting
  • Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • Improved BEAM regimen
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Dec 26, 2022

Primary CNS Lymphoma Trial in Stuttgart (Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix,

Recruiting
  • Primary Central Nervous System Lymphoma
  • Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix
  • Control intervention: four courses of MATRix
  • Stuttgart, Baden-Württemberg, Germany
    Klinikum Stuttgart
Feb 15, 2022

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Seattle (procedure,

Completed
Has Results
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 29, 2020

HIV, Burkitt's Lymphoma Trial in Italy (Induction Phase, Consolidation Phase (on day +50), Intensification phase)

Completed
  • HIV
  • Burkitt's Lymphoma
  • Induction Phase
  • +4 more
  • Aviano (PN), Italy
  • +7 more
Aug 2, 2022

Recurrent DLBCL Activated B-Cell Type, Refractory DLBCL Activated B-Cell Type Trial in Saudi Arabia, United States (procedure,

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type
  • Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type
  • Autologous Bone Marrow Transplantation
  • +10 more
  • Anchorage, Alaska
  • +282 more
Aug 19, 2022

Relapsed Follicular Lymphoma Trial in Italy (ZEVALIN, BEAM)

Active, not recruiting
  • Relapsed Follicular Lymphoma
  • Genova, GE, Italy
  • +37 more
Dec 22, 2022

Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Non-Hodgkin Trial in United States (Autologous transplantation

Completed
Has Results
  • Lymphoma, B-Cell
  • +2 more
  • Autologous transplantation using rituxan/BEAM
  • Autologous transplantation using Bexxar/BEAM
  • New Haven, Connecticut
  • +35 more
Oct 21, 2021

Lymphoma, Large-Cell, Diffuse Trial in Worldwide (Rituximab, Etoposide, Carboplatine)

Completed
  • Lymphoma, Large-Cell, Diffuse
  • New York, New York
  • +9 more
Aug 22, 2019

Glioblastoma Multiforme Trial in Milan, Rome (Temferon)

Recruiting
  • Glioblastoma Multiforme
  • Milan, Italy
  • +2 more
Feb 8, 2021